Cargando…
Cancer immunotherapy: broadening the scope of targetable tumours
Cancer immunotherapy has experienced remarkable advances in recent years. Striking clinical responses have been achieved for several types of solid cancers (e.g. melanoma, non-small cell lung cancer, bladder cancer and mismatch repair-deficient cancers) after treatment of patients with T-cell checkp...
Autores principales: | van den Bulk, Jitske, Verdegaal, Els ME, de Miranda, Noel FCC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030119/ https://www.ncbi.nlm.nih.gov/pubmed/29875199 http://dx.doi.org/10.1098/rsob.180037 |
Ejemplares similares
-
Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021) -
Neoantigen Targetability in Progressive Advanced Melanoma
por: van den Bulk, Jitske, et al.
Publicado: (2023) -
Broadening the Scope…
por: Bradshaw, Ralph A.
Publicado: (2020) -
Broadening the scope of sortagging
por: Dai, Xiaolin, et al.
Publicado: (2019) -
Eukaryotic systems broaden the scope of synthetic biology
por: Haynes, Karmella A., et al.
Publicado: (2009)